I hear you Singhgu , But Big Pharma are not gamblers they are also looking for certainty, Yes the Cohort has been small but its the mechanism of action that DXB are proving.
Your own statement rings true
" it makes sense for them to wait for 1st interim results and make a move if it turns out to be positive." plus DXB will be able to negotiate from a stronger position with all of the data...NZT
Ann: Successful Completion of DSMB Review of Phase 3 FSGS Trial, page-26
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $206.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $517.8K | 1.383M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 640 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 75747 | 4 |
View Market Depth
| Last trade - 15.40pm 15/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |